Stay updated with breaking news from பார்டி பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MedCity News Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash. Shares0 In another deal for cardiac monitoring, Hillrom (NYSE: HRC) will buy Seattle-based startup Bardy Diagnostics for $375 million. The company, which was founded in 2013 by electrophysiologist Dr. Gust Bardy, makes an electrocardiogram (ECG) patch that can be worn for up to two weeks to help physicians detect arrhythmias. In addition to its technology, Bardy Diagnostics’ 230 employees are expected to join the company, Hillrom President and CEO John Grotelaars said in a news release. ....
Share Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The $375 million deal is expected to close during fiscal Q2 2021. Bardy s flagship product is the Carnation Ambulatory Monitor, often referred to as the CAM patch. It s a P-wave signal-capturing wearable that is placed along the sternum, where it can remotely monitor patients’ cardiac activity or detect arrhythmia over a seven-day period. The patch s readings are uploaded to Bardy s companion patient management portal, which providers can use to access reports or receive monitoring alerts. ....